US$ 21.00
clinical trial glp 1 GLP1 agonists: current and future landscape of trials for patients with metabolic dysfunction GLP-1a: Going beyond Traditional Use
Description
Safety profile from completed Phase 2 trials shows retatrutide is comparable to FDA-approved alternatives

, Sun, J

The brief duration of action means that endogenous GLP-1 functions as a meal-related signal rather than providing sustained metabolic control

J.LeP.BoyerC
Blood sugar can rise when the medication stops, which is one more reason stopping should never be a solo decision if youre diabetic

To be eligible, participants had to occasionally drink alcohol, be 21 years of age or older, and have a BMI of 30 or greater
